leisure time -WSS

leisure time

author：explore 2025-09-30 14:58:43 - browse：6

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Stroke rates rising, especially in working

focus

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

J&J reports mixed data on next

Decentralized clinical trials need collaboration to achieve wider use

Food makers tried to stack nutrition panel with preferred experts

Medical students need to learn the potent medicine of empathy

Why some fertility treatments produce more boy babies

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

New weight loss drugs vying to be the next Wegovy or Mounjaro

Hepatitis C has a cure — but many Americans still lack access to it

J&J reports mixed data on next

Malaria cases in Florida and Texas: Here’s what you need to know

Telehealth for opioid use disorder is lifesaving

Medical records are filled with copy

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Congress: Prevent baby formula shortages by passing a new bill

knowledge

Achieving telehealth equity for people with hearing loss

Protect nursing home residents from future pandemics

Some medical students still think black patients feel less pain

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

New research sheds light on how often breast cancer is overdiagnosed

FDA proposes changes to key medical devices approval pathway

focus

hotspot

hotspot

knowledge